Adverse effects · children aged 5 to 14 years with overactive bladder and at least one episode of daytime urinary incontinence per week
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects · Adults with overactive bladder (OAB)
It is very uncertain whether electrical stimulation plus drug therapy changes adverse effects compared with drug therapy alone (very low certainty).
1 finding from 1 review
Adverse effects · Adults with overactive bladder (OAB)
1 finding from 1 review
Adverse effects · children aged 3 to 17 years with daytime urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects · children aged 5 to 16 years with daytime urinary incontinence
1 finding from 1 review
Adverse effects · children aged 5 to 16 years with daytime urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects · children aged 5 to 15 years with dysfunctional elimination syndrome, 41/59 with daytime urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor adverse effects: vaginal events · women with POP
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor adverse effects: vaginal events · women with POP
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor adverse effects: vaginal events · women with POP
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor adverse effects: vaginal events · women with POP
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects · women with stress urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects ‐ ES versus oxybutynin · Adults with overactive bladder (OAB)
Electrical stimulation may leads to lower adverse effects ‐ ES versus oxybutynin compared with drug therapy (low certainty).
1 finding from 1 review
Adverse effects ‐ ES versus tolterodine · Adults with overactive bladder (OAB)
Electrical stimulation probably leads to lower adverse effects ‐ ES versus tolterodine compared with drug therapy (moderate certainty).
1 finding from 1 review
Adverse effects ‐ ES versus solifenacin succinate · Adults with overactive bladder (OAB)
It is very uncertain whether electrical stimulation changes adverse effects ‐ ES versus solifenacin succinate compared with drug therapy (very low certainty).
1 finding from 1 review
Adverse effects ‐ oestrogen vs PPA · patients with urinary incontinence in post‐menopausal women
1 finding from 1 review
Number with adverse effects ‐ Local administration · patients with urinary incontinence in post‐menopausal women
Oestrogen showed no clear difference in number with adverse effects ‐ Local administration compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Number with adverse effects ‐ Systemic administration · patients with urinary incontinence in post‐menopausal women
Oestrogen may leads to higher number with adverse effects ‐ Systemic administration compared with placebo or no treatment (low certainty).
1 finding from 1 review